| Temozolomide Accord 140 mg hard capsules EU/1/10/615/013-014 |
Temozolomide |
Accord Healthcare S.L.U. |
— |
| Temozolomide Accord 180 mg hard capsules EU/1/10/615/017-018 |
Temozolomide |
Accord Healthcare S.L.U. |
— |
| Temozolomide Accord 20 mg hard capsules EU/1/10/615/005-006 |
Temozolomide |
Accord Healthcare S.L.U. |
— |
| Temozolomide Accord 250 mg hard capsules EU/1/10/615/021-022 |
Temozolomide |
Accord Healthcare S.L.U. |
— |
| Temozolomide Accord 5 mg hard capsules EU/1/10/615/001-002 |
Temozolomide |
Accord Healthcare S.L.U. |
— |
| Temozolomide Teva 100 mg hard capsules EU/1/09/606/005-006 |
Temozolomide |
Teva B.V. |
— |
| Temozolomide Teva 140 mg hard capsules EU/1/09/606/007-008 |
Temozolomide |
Teva B.V. |
— |
| Temozolomide Teva 180 mg hard capsules EU/1/09/606/009-010 |
Temozolomide |
Teva B.V. |
— |
| Temozolomide Teva 20 mg hard capsules EU/1/09/606/003-004 |
Temozolomide |
Teva B.V. |
— |
| Temozolomide Teva 250 mg hard capsules EU/1/09/606/011-012 |
Temozolomide |
Teva B.V. |
— |
| Temozolomide Teva 5 mg hard capsules EU/1/09/606/001-002 |
Temozolomide |
Teva B.V. |
— |
| Tenkasi 1200 mg powder for concentrate for solution for infusion EU/1/15/989/002 |
Oritavancin |
Menarini International Operations Luxembourg S.A. |
— |
| Tenkasi 400 mg powder for concentrate for solution for infusion EU/1/15/989/001 |
Oritavancin |
Menarini International Operations Luxembourg S.A. |
— |
| Tenofovir disoproxil Viatris 245 mg film-coated tablets EU/1/16/1129/001 |
Tenofovir disoproxil |
Viatris Limited |
— |
| Tenofovir disoproxil Zentiva 245 mg film-coated tablets EU/1/16/1127/001-002 |
Tenofovir disoproxil phosphate |
Zentiva k.s. |
— |
| TEPADINA 100 mg powder for concentrate for solution for infusion EU/1/10/622/002 |
Thiotepa |
Adienne S.r.l. |
— |
| TEPADINA 15 mg powder for concentrate for solution for infusion EU/1/10/622/001 |
Thiotepa |
Adienne S.r.l. |
— |
| TEPADINA 200 mg powder and solvent for solution for infusion EU/1/10/622/004 |
Thiotepa |
Adienne S.r.l. S.U. |
— |
| TEPADINA 400 mg powder and solvent for solution for infusion EU/1/10/622/003 |
Thiotepa |
Adienne S.r.l. S.U. |
— |
| TEPEZZA 500 mg powder for concentrate for solution for infusion EU/1/25/1941/001 |
Teprotumumab |
Amgen Europe B.V., |
— |
| Tepkinly 4 mg/0.8 ml solution for injection EU/1/23/1759/001 |
Epcoritamab |
AbbVie Deutschland GmbH & Co. KG |
— |
| Tepkinly 48 mg solution for injection EU/1/23/1759/002 |
Epcoritamab |
AbbVie Deutschland GmbH & Co. KG |
— |
| TEPMETKO 225 mg film-coated tablets EU/1/21/1596/001 |
Tepotinib hydrochloride monohydrate |
Merck Europe B.V. |
— |
| Terbinafine Rowa 250 mg tablets PA0074/084/001 |
Terbinafine |
Rowa Pharmaceuticals Limited |
Marketed |
| Teriflunomide Accord 14 mg film-coated tablets EU/1/22/1693/001-004 |
Teriflunomide |
Accord Healthcare S.L.U. |
— |
| Teriflunomide Accord 7 mg film-coated tablets EU/1/22/1693/005-012 |
Teriflunomide |
Accord Healthcare S.L.U. |
— |
| Teriflunomide Viatris 14 mg film-coated tablets EU/1/22/1698/001-007 |
Teriflunomide |
Mylan Pharmaceuticals Limited |
— |
| Teriparatide SUN 20 micrograms/80 microliters solution for injection in pre-filled pen EU/1/22/1697/001-002 |
Teriparatide |
Sun Phamaceutical Industries Europe B.V. |
— |
| Terrosa 20 micrograms/80 microliters solution for injection EU/1/16/1159/001-002 |
Teriparatide |
Gedeon Richter Plc |
— |
| Tesavel 100 mg film-coated tablets EU/1/07/435/13-18 |
Sitagliptin as monohydrate phosphate salt |
Merck Sharp & Dohme BV |
— |
| Tesavel 25 mg film-coated tablets EU/1/07/435/1-6 |
Sitagliptin as monohydrate phosphate salt |
Merck Sharp & Dohme BV, |
— |
| Tesavel 50 mg film-coated tablets EU/1/07/435/7-12 |
Sitagliptin as monohydrate phosphate salt |
Merck Sharp & Dohme BV |
— |
| Testogel 50 mg transdermal gel in sachet PPA23080/032/001 |
Testosterone |
Merit Pharmaceuticals Limited |
— |
| Tetravac, suspension for injection in prefilled syringe Diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine, (adsorbed). PA23458/007/001 |
Adsorbed purified pertussis toxoid, Adsorbed purified filamentous haemagglutinin, Purified tetanus toxoid, Purified diphtheria toxoid ph. eur., Inactivated type 1 poliovirus |
Sanofi Winthrop Industrie |
Marketed |
| Tevagrastim 30 MIU/0.5 mL solution for injection/infusion EU/1/08/445/1-4 |
Filgrastim |
Teva Generics GmbH |
— |
| Tevagrastim 48 MIU/0.8 mL solution for injection/infusion EU/1/08/445/5-8 |
Filgrastim |
Teva Generics GmbH |
— |
| Tevimbra 100 mg concentrate for solution for infusion EU/1/23/1758/001-002 |
Tislelizumab |
BeiGene Ireland Limited |
— |
| Teysuno 15 mg/4.35 mg/11.8 mg hard capsules EU/1/11/669/001-002 |
Tegafur, Gimeracil, Oteracil (as monopotassium salt) |
Nordic Group B.V. |
— |
| Teysuno 20 mg/5.8 mg/15.8 mg hard capsules EU/1/11/669/003-004 |
Gimeracil, Oteracil (as monopotassium salt), Tegafur |
Nordic Group B.V. |
— |
| Tezspire 210 mg solution for injection in pre-filled syringe EU/1/22/1677/001-002 |
Tezepelumab |
AstraZeneca AB |
— |
| Thalidomide BMS 50 mg hard capsules EU/1/08/443/1 |
Thalidomide |
Bristol-Myers Squibb Pharmaceuticals uc |
— |
| Thalidomide Lipomed 100 mg coated tablets EU/1/22/1676/001 |
Thalidomide |
Lipomed GmbH |
— |
| Theralugand EU/1/24/1852/001-002 |
Lutetium (177lu) chloride |
Eckert & Ziegler Radiopharma GmbH |
— |
| Thiotepa Fresenius Kabi 100 mg powder for concentrate for solution for infusion PA2059/079/002 |
Thiotepa |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Thiotepa Fresenius Kabi 15 mg powder for concentrate for solution for infusion PA2059/079/001 |
Thiotepa |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Thiotepa Riemser 100 mg powder for concentrate for solution for infusion EU/1/21/1536/002 |
Thiotepa |
Esteve Pharmaceuticals GmbH |
— |
| Thiotepa Riemser 15 mg powder for concentrate for solution for infusion EU/1/21/1536/001 |
Thiotepa |
Esteve Pharmaceuticals GmbH |
— |
| Thorinane EU/1/16/1131/001-002 |
Enoxaparin sodium |
Techdow Pharma Netherlands B.V |
— |
| Thorinane EU/1/16/1131/003-004 |
Enoxaparin sodium |
Pharmathen S.A. |
— |
| Thorinane EU/1/16/1131/005-006 |
Enoxaparin sodium |
Pharmathen S.A. |
— |